|
STMN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.87982962529532E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.02458058598631E-12 |
| Normal-vs-Stage2 |
6.579700E-04 |
| Normal-vs-Stage3 |
1.23559995568456E-09 |
| Normal-vs-Stage4 |
1.24419999969483E-07 |
| Stage1-vs-Stage2 |
1.736410E-01 |
| Stage1-vs-Stage3 |
9.048200E-01 |
| Stage1-vs-Stage4 |
6.222600E-01 |
| Stage2-vs-Stage3 |
1.928640E-01 |
| Stage2-vs-Stage4 |
3.974200E-01 |
| Stage3-vs-Stage4 |
6.061800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.38444811170757E-13 |
| Normal-vs-AfricanAmerican |
1.404290E-03 |
| Normal-vs-Asian |
1.10499998040581E-09 |
| Caucasian-vs-AfricanAmerican |
3.889600E-01 |
| Caucasian-vs-Asian |
9.769000E-01 |
| AfricanAmerican-vs-Asian |
3.295200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.79679995513527E-10 |
| Normal-vs-Female |
4.52815562823616E-12 |
| Male-vs-Female |
8.391200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.77025061276481E-12 |
| Normal-vs-Age(41-60Yrs) |
1.45019996011797E-09 |
| Normal-vs-Age(61-80Yrs) |
1.21589999957372E-07 |
| Normal-vs-Age(81-100Yrs) |
5.935500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.733600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.651000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.988400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.631200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.027800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.429400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.596830E-01 |
| Classical-VS-Follicular |
2.18360000003859E-06 |
| Classical-VS-Other |
6.081800E-01 |
| Classical-VS-Normal |
1.64990243689545E-12 |
| Tall-VS-Follicular |
8.19780000000936E-05 |
| Tall-VS-Other |
9.391400E-01 |
| Tall-VS-Normal |
2.51370000370343E-08 |
| Follicular-VS-Other |
1.782770E-01 |
| Follicular-VS-Normal |
5.555400E-03 |
| Other-VS-Normal |
6.347600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.67849980978485E-10 |
| Normal-vs-N1 |
3.34969999959966E-07 |
| N0-vs-N1 |
6.339000E-01 |
|
|
